Pleural mesothelioma in Costa Rica
DOI:
https://doi.org/10.51481/amc.v48i1.217Keywords:
mesotelioma, mesotelioma pleural, tumores pleuralesAbstract
After reviewing the pathology service archives of the 3national general hospitals of the Costarrican Social SecurityHealth System, 29 cases of pleural mesothelioma werefound between 1972 and 2002. The incidence rate in 2002was 1 case per 2 million; there were 15 females and 14males, with a mean age of 54 years. Twenty cases present-ed with pleural effusion being dyspnea, chest pain, cough,fever and weight loss the most frequent symptoms.
The disease was detected in all the cases because of anabnormal chest X-ray. The method used to obtain tissue forhistological diagnosis was thoracotomy for 15 cases, pleu-ral biopsy in 8, thoracoscopy in 4 and autopsy in 2.
The histological diagnosis in 16 cases was fibrousmesothelioma, 10 malignant and 6 benign, 12 were epithe-lial (all malignant) and 2 were malignant mixed mesothe-liomas.
The treatment in all the benign cases was surgicalresection and none recurred. Two of the malignant lesionswere resected, 1 had an extrapleural pneumonectomy alongwith pericardial and diaphragmatic resection, but the sur-vival was not better than the rest of the malignant cases,with an average survival rate for all of them of only 6months. Chemotherapy and radiotherapy showed no addi-tional Benefit.
Downloads
References
Craighead JE. Current pathogenic concepts of diffuse malignantmesothelioma. Human Path. 1987; 18:544-557.
Buntom RW, Borrie J. Pleural fibromas: a clinical review and reportof six patients. Ann Thorac Surg 1982; 33:609-613.
Scharifker D, Kaneko M. Localized fibrous "mesothelioma"of pleura (submesothelial fibroma): A clinicophatologic study of 18cases. Cancer 1979; 43:627-635.
Stout AP, Murray MR. Localized pleural mesothelioma. Arch Pathol1942; 34:951.
Klemperer P, Rabin CB. Primary neoplasms of the pleura. A report offive cases. Arch Patol 1937; 11:385-412.
Borrow M, Coston A, Livornese LL, Schalet N. Mesothelioma and itsassociation with asbestosis. JAMA 1967; 201:587-591.
Wagner JC, Sleeg CA, Marchand P. Diffuse pleural mesotheliomaand asbestos exposure in Northwestern Cape Province. Br J Ind Med1960; 17:260-271.
Selikoff IJ, Churg J, Hammond EC. Relation between exposure toasbestos and mesothelioma. N Engl J Med 1965; 272:560-565.
Fower PBS, Sloper JC, Warner EC. Exposure to asbestos andmesothelioma of the pleura. BMJ 1964; 2:211-213.
Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia.JAMA 1964; 188.122-26.28
Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos diseaseamong insulation workers in the United States and Canada. Cancer1980; 46:2736-2740.
Mottprize CS. Mesothelioma and mineral fibers. Cancer 1986;57:1905-11.
Whitwell F, Rawcliffe RM. Diffuse malignant pleural mesotheliomaand asbestos exposure. Thorax 1971; 26:6-22.
Antman KH. Clinical presentation and natural history of benign andmalignant mesothelioma. Semin Oncol 1981; 8:313-320.
Anderson HA, Lilis R, Daum SM, y cols. Household-contact asbestosneoplastic risk. Ann N Y Acad Med 1976; 271:311-23.
Li FP, Lokich J. Familial mesothelioma after intense asbestos expo-sure at home. JAMA 1978; 240:467
Mossman BT, Gee JBL. Asbestos related diseases. N Engl J Med1989; 320:1721-1730.
McDonald JC, McDonald AD. Epidemiology of mesothelioma fromestimated incidence. Prev Med 1977; 6:426-446.
Stein RC, Kitajewska JY, Kirkham JB, Taitt N, Sinha G, Rudd RM.Pleural mesothelioma resulting from exposure to amosite asbestos ina building. Respir Med 1989; 83: 237-239.
Russell JN, Osteen RT, Antman KH, Koster JK. Clinical staging andthe tendency of malignant pleural mesothelioma to remain localized.Ann Thorac Surg 1982;34:66-70.
Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestosworkers: implications for models of carcinogenesis and risk assess-ment. Br J Cancer 1981; 44:1-12.
Penfield LF. Surgical treatment of asbestos related disease of thechest. Surg Clin North Am 1988; 68:525-543.
Segura JJ, Mesoteliomas de la pleura. Acta Med Costarric 1974; 17:18.
McDonald AD, McDonald JC, Malignant mesothelioma in NorthAmerica. Cancer. 1980; 46:1650-1656.
Smith DD. Women and mesothelioma. Chest. 2002; 122:1885-1886.
Aisner J. Current approach to malignant mesothelioma of the pleura.Chest 1995; 107:332S-344S.
Rusch VW, Venkatraman E. The importance of surgical staging in thetreatment of malignant pleural mesothelioma. J Thorac CardiovascSurg 1996; 111:815-826.
Hillerdal G. Malignant mesothelioma 1982: review of 4710 publishedcases. Br J Dis Chest 1983; 77:321-343.
Anderson N, Lokish JJ. Mesenchymal tumors associated with hypo-glycemia. Cancer 1979; 44:785-790.
Borden EC. Mesothelioma: natural history and current therapeuticapproaches. Current Concepts in Oncology. 1983; 3-8.
National occupational health and safety commission. Australianmesothelioma register report, 1999. The incidence of mesotheliomain Australia 1994 to 1996. 1999; 1-3.
Bertram P. Analysis of current trends in United States. Mesotheliomaincidence. Am J Epidemiol 1997; 145:211-18
Hillerdal G, Baris Y. Radiological study of pleural changes in relationto mesothelioma in Turkey. Thorax 1983; 38:443-448.
Borow M, Conston A, Livornese L, Schalet N. Mesothelioma and itsassociation with asbestosis. JAMA 1967; 201:587-591.
Metintas S, Metintas M, Uogun I, Oner U. Malignant mesotheliomadue to environmental exposure to asbestos: follow-up of a Turkishcohort living in a rural area. Chest 2002; 122:1885-1886.
Lerner HJ, Schoenfeld DA, Martin A, Falkson G, Borden E.Malignant mesothelioma. The eastern cooperative oncology group(ECOG) experience. Cancer 1983; 52:1981-1985.
Pillgram-Larsen J, Urdal L, Smith-Meyer R, Birkeland S. Malignantpleural mesothelioma. Scand J Cardiovasc Surg 1984; 18:69-73.
Watts DM, Jones GP, Bowman GA, Olsen JD. Giant BenignMesothelioma. Ann Thorac Surg 1989; 48:590-591.
August JT, Hiatt HH, Severe hypoglycemia secondary to a nonpan-creatic fibrosarcoma with insulin activity. N Engl J Med 1958;258:17-20.
McCormack PM, Nagasaki F, Hilaris BS, Martini N. SurgicalTreatment of pleural mesothelioma. J Thorac Cardiovasc Surg. 1982;84:834-842.
Aisner J, Wiernik P. Malignant Mesothelioma. Current status andfuture prospects. Chest 1978; 74:438-443.
Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CTmanifestations in 50 cases. Am J Radiol 1990; 155:965-969.
Butchart EG, Ashcroft T, Barnsley WC, Holden MP.Pleuroneumonectomy in the management of diffuse malignantmesothelioma of the pleura. Experience with 29 patients. Thorax1976; 34:15-24.
International Mesothelioma Interest Group. A proposed new interna-tional TNM staging system for malignant pleural mesothelioma.Chest 1995; 108:1122-1128
Pass HI. Pleural mesothelioma in 2002: Going somewhere very slow-ly. J Thorac Cardiovasc Surg 2002; 124:1074-1077.
Sugarbaker DJ, García JP. Multimodality therapy for malignant pleu-ral mesothelioma. Chest 1997; 272S-275S.
Fernández MC, García JL, Simón JL, Maillo M, Jiménez MJ.Radioterapia externa en el mesotelioma pleural maligno. Oncología.1994; 17:335-340.
Roberts JR. Innovative therapies for malignant pleural mesothelioma.Chest 1997; 269S-271S
Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, MandelEM. Diffuse Malignant Mesothelioma. Prospective evaluation of 69patients. Ann Intern Med. 1982; 96:746-755.
Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothe-lioma of the pleura. Review of 123 patients. Cancer 1982;49:2431.2435.
Sugarbaker DJ, García JP, Richards WG, y colrs. Extrapleural pneu-monectomy in the multimodality therapy of malignant pleuralmesothelioma. Results in 120 consecutive patients. Ann Surg 1996;224:288-296.
Lewis RJ, Sisler GE, Mackenzie JW. Diffuse, mixed malignantmesothelioma. Ann Thorac Surg 1981; 31:53-60.
Lee TT, Everett DL, Shu HG, Jahan TM, y colrs. Radical pleurecto-my, decortication and intraoperative radiotherapy followed by formalradiation with or without chemotherapy for malignant pleuralmesothelioma. J Thorac Cardiovasc Surg 2002; 124:1183-1188.
Rusch VW, Venkatraman ES. Important prognostic factors in patientswith malignant pleural mesothelioma, managed surgically. AnnThorac Surg 1999; 68:1799-1802.
Zellos L, Sugarbaker DJ. Current surgical management of malignantpleural mesothelioma. Curr Oncol Rep 2002; 4:354-360.
Sugarbaker DJ, Jaklitsch MT, Liptay MJ. Mesothelioma and radicalmultimodality therapy: Who benefits? Chest 1995; 107:345S-305S.
Bonnette P, Heckly GB, Villette S, Fragola A. Intraoperative photo-dynamic therapy after pleuropneumonectomy for malignant pleuralmesothelioma. Chest 2002; 122:1866-1867.
Bree E, van Ruth S, Bass P y colrs. Cytoreductive surgery and intra-operative hypertermic chemotherapy in patients with malignant pleu-ral mesothelioma or pleural metastases of thymoma. Chest 2002;121:480-487
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
